Biotech

Latest Articles

Cassava pays for $40M over supposedly deceiving Alzheimer's upgrade

.Cassava Sciences has actually consented to spend $40 million to solve an inspection right into clai...

Merck bags options on Evaxion's AI-designed vaccine candidates

.Merck &amp Co. has gotten alternatives on 2 Evaxion Biotech vaccination candidates, paying $3.2 mil...

Enanta's RSV antiviral crushes virus-like load in difficulty research

.Enanta Pharmaceuticals has connected its respiratory syncytial infection (RSV) antiviral to substan...

Biogen containers SAGE-324 partnership after crucial shake neglect

.Biogen has conducted the last rites to its partnership with Sage Therapeutics on SAGE-324, ditching...

AbbVie Parkinson's drug from $8.7 B Cerevel purchase scores

.On the very same day that some Parkinson's illness drugs are being brought into question, AbbVie ha...

Arch shuts $3B-plus fund to promote biopharma upstarts

.On the heels of a $3 billion fund from Bain Funds Lifestyle Sciences, Arch Project Partners is actu...

Orion to use Aitia's 'electronic identical twins' to discover new cancer cells medications

.Finnish biotech Orion has actually spied prospective in Aitia's "electronic twin" specialist to bui...

Windtree's surprise med raises high blood pressure in most up-to-date phase 2 win

.While Windtree Rehabs has had a hard time to grow the financial origins required to survive, a phas...

2 cancer biotechs merge, making international footprint

.OncoC4 is taking AcroImmune-- and its own in-house scientific production capabilities-- under its o...

Amgen records very first stage 3 win for $400M chronic eczema medicine

.Amgen has actually discussed (PDF) the 1st period 3 records on its $400 million chronic eczema drug...

Biogen, UCB report stage 3 lupus gain after stopping working earlier trial

.Biogen as well as UCB's rely on developing into period 3 astride a broken study aims to have paid, ...

Aptadir wishes brand-new RNA inhibitors can easily turn around challenging cancers

.Italian biotech Aptadir Rehabs has actually launched with the assurance that its own pipe of precli...

Wave surfs DMD excellence to regulators' doors, delivering stock up

.Surge Life Sciences has fulfilled its own target in a Duchenne muscle dystrophy (DMD) research, ins...

Sanofi picks new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is going back to the pharma crease, takin...

Achilles droplets tissue treatment course, bandages for discharges after missing 'business feasibility' goals

.Achilles Therapies has torn up its approach. The English biotech is actually quiting working on its...

Aligos heralds period 2 MASH succeed, lowering liver excess fat as much as 46%

.Aligos Therapeutics is advertising a midstage win in metabolic-dysfunction affiliated steatohepatit...

Basilea ratings $268M BARDA backing for antifungals, antibiotics

.Basilea Pharmaceutica's job developing brand-new antifungals has actually received a notable boost ...

Capricor markets Europe civil liberties to late-stage DMD treatment for $35M

.Having actually scooped up the USA liberties to Capricor Rehabs' late-stage Duchenne muscular dystr...

FDA junks adcomm for Applied's uncommon illness drug

.After dismissing the selection date for Applied Therapies' metabolic problem medicine govorestat, t...

Novo inks $600M NanoVation deal to examine genetic medications ex-liver

.Novo Nordisk is actually continuing its own press right into hereditary medications, accepting pay ...